Home › NDC Lookup › RxCUI directory › RxCUI 2720539

3 ML insulin aspart-xjhz 100 UNT/ML Pen Injector — RxCUI 2720539

Name: 3 ML insulin aspart-xjhz 100 UNT/ML Pen Injector (RxCUI 2720539)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2720539 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2720539

Official name3 ML insulin aspart-xjhz 100 UNT/ML Pen Injector

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asinsulin aspart-xjhz 100 UNT/ML per 3 ML Pen Injector; insulin aspart-xjhz 100 UNT/ML in 3 ML Pen Injector

FDA products mapped3

Package NDCs mapped3

Reported Medicaid activity (SDUD)729 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Insulin Aspart (rDNA Origin) Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It helps control blood sugar in people with diabetes mellitus. The 70/30 mix is for adults, while other products like NovoLog and Fiasp are mealtime insulins. The mix is not for di...
NovoLog is injected under the skin within 5 to 10 minutes before a meal. Rotate sites among your belly, thigh, buttocks or upper arm. Follow your prescriber’s plan and your product...
Low blood sugar. Shakiness, sweating or confusion can be warning signs, though they can be subtle. Check your sugar often and carry fast-acting sugar. Severe lows need emergency he...
What side effect should I watch for most?

📖 Read our full Insulin Aspart (rDNA Origin) Injection guide →

🕸️ Concept Web — How 3 ML insulin aspart-xjhz 100 UNT/ML Pen Injector Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 3 ML insulin aspart-xjhz 100 UNT/ML Pen Injector RxCUI 2720539 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Insulin aspart, human 51428 IN
- Insulin aspart-xjhz 2720519 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Kirsty 2720524 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Insulin aspart, human Pen Injector 1653201 SCDF
- Insulin aspart-xjhz Pen Injector 2720531 SCDFP
- Insulin aspart, human Injectable Product 1157463 SCDG
- Insulin aspart-xjhz Injectable Product 2720521 SCDGP
- Insulin aspart, human Pen Injector [Kirsty] 2720535 SBDF
- Insulin aspart-xjhz Pen Injector [Kirsty] 2720536 SBDFP
- Kirsty Injectable Product 2720526 SBDG
- Pen Injector 1649571 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Insulin aspart-xjhz 100 UNT/ML 2720520 SCDC
- 3 ML insulin aspart-xjhz 100 UNT/ML Pen Injector [Kirsty] 2720541 SBD
- Insulin aspart-xjhz 100 UNT/ML [Kirsty] 2720525 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Insulin aspart-xjhz 100 UNT/ML SCDC · 2720520
Insulin aspart, human Pen Injector SCDF · 1653201
Insulin aspart-xjhz Pen Injector SCDFP · 2720531
Insulin aspart, human Injectable Product SCDG · 1157463
Insulin aspart-xjhz Injectable Product SCDGP · 2720521

Brand-Name Concepts

3 ML insulin aspart-xjhz 100 UNT/ML Pen Injector [Kirsty] SBD · 2720541
Insulin aspart-xjhz 100 UNT/ML [Kirsty] SBDC · 2720525
Insulin aspart, human Pen Injector [Kirsty] SBDF · 2720535
Insulin aspart-xjhz Pen Injector [Kirsty] SBDFP · 2720536
Kirsty Injectable Product SBDG · 2720526
Kirsty BN · 2720524

📦 FDA Products & Package NDCs

3 products · 3 package NDCs

3 package NDCs map to RxCUI 2720539 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
83257-0006-11	1 VIAL, MULTI-DOSE in 1 CARTON (83257-006-11) / 10 mL in 1...	INSULIN DILUTING MEDIUM FOR Kirsty	Biocon Biologics Inc.	2025-09-15
83257-0007-11	1 VIAL, MULTI-DOSE in 1 CARTON (83257-007-11) / 10 mL in 1...	KIRSTY	Biocon Biologics Inc.	2025-09-15
83257-0008-32	5 SYRINGE in 1 CARTON (83257-008-32) / 3 mL in 1 SYRINGE (8...	KIRSTY	Biocon Biologics Inc.	2025-09-15

Observed labelers: Biocon Biologics Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.